ID: ALA3276697

Max Phase: Preclinical

Molecular Formula: C12H22ClN

Molecular Weight: 179.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NCC12CCCC3CC(CCC31)C2

Standard InChI:  InChI=1S/C12H21N.ClH/c13-8-12-5-1-2-10-6-9(7-12)3-4-11(10)12;/h9-11H,1-8,13H2;1H

Standard InChI Key:  UYONWVAVMBPXCA-UHFFFAOYSA-N

Associated Targets(non-human)

Newcastle disease virus (78 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 179.31Molecular Weight (Monoisotopic): 179.1674AlogP: 2.55#Rotatable Bonds: 1
Polar Surface Area: 26.02Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.90CX LogP: 2.24CX LogD: -0.14
Aromatic Rings: 0Heavy Atoms: 13QED Weighted: 0.66Np Likeness Score: 1.67

References

1. Aigami K, Inamoto Y, Takaishi N, Fujikura Y..  (1976)  Biologically active polycycloalkanes. 2. Antiviral 4-homoisotwistane derivatives.,  19  (4): [PMID:1263206] [10.1021/jm00226a018]

Source